Navigation Links
Oncolytics Biotech(R) Inc. Research Collaborators Present Glioma Reovirus Research at ASV Annual Meeting
Date:7/15/2009

CALGARY, July 15 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY) announced today that a poster presentation by Dr. Jacqueline Parker et al. entitled "Anti-Tumor Activity of Reovirus is Synergistically Enhanced in Combination with Temozolomide and Low Dose Irradiation in Primary Patient Glioma Xenografts Resistant to Treatment with Either Therapy Alone" was made yesterday at the 28th American Society for Virology (ASV) Annual Meeting. The meeting is being held in Vancouver, British Columbia, from July 11-15, 2009.

"These results support the strategic direction we're taking with the REOLYSIN(R) clinical program," said Dr. Matt Coffey, Chief Operating Officer for Oncolytics. "The future program for REOLYSIN, including our pivotal program, is focused on exploiting these underlying drug synergies."

The poster covers preclinical work using reovirus in combination with low dose irradiation (IR) and temozolomide (TMZ). A panel of glioma cell lines and primary patient glioma explant cells were tested for susceptibility to reovirus, IR, TMZ, or a combination of these therapies in vitro. The combination index analyses revealed moderate to strong synergy in primary patient glioma cells treated with reovirus plus IR and TMZ in vitro. This effect was also seen in vivo in flank tumor xenografts from primary patient tumors resistant to reovirus therapy alone.

The investigators concluded that the data supports the use of reovirus in combination with standard radiation and chemotherapies for the treatment of malignant glioma in humans.

The poster will be available on the Oncolytics website at www.oncolyticsbiotech.com at a later date.

About Oncolytics Biotech Inc.

Oncolytics is a Calgary-based biotechnology company focused on the de
'/>"/>

SOURCE Oncolytics Biotech Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Oncolytics Biotech(R) Inc. Completes Patient Enrolment in U.K. Combination REOLYSIN(R) and Paclitaxel/Carboplatin Head and Neck Cancer Trial
2. Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at ASCO Annual Meeting
3. Oncolytics Biotech(R) Inc.s Research Collaborators to Present Data on REOLYSIN(R) Clinical Trials at ASCO Conference
4. Oncolytics(R) Biotech Inc. Completes Patient Enrolment in U.S. Phase 2 Sarcoma Study
5. Oncolytics Biotech(R) Inc. Announces 2009 First Quarter Results
6. Oncolytics Biotech(R) Inc. Announces Details of 2009 Annual Shareholder Meeting
7. Media Advisory - Oncolytics Biotech(R) Inc. to Present at BioFinance 2009
8. Oncolytics Biotech(R) Inc. Announces Positive Results of U.K. Phase II REOLYSIN(R) and Radiation Combination Clinical Trial
9. Oncolytics Biotech(R) Inc. Completes Enrolment in Combination REOLYSIN(R)/Gemcitabine Trial
10. Oncolytics Biotech(R) Inc. Collaborators Present Reovirus Research at Replicating Oncolytic Virus Meeting
11. Oncolytics Biotech(R) Inc. Collaborators Present Positive Head and Neck Results in Phase I/II Combination REOLYSIN(R) and Paclitaxel/Carboplatin Trial

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)... , , , , , , , ... A team of scientists from Washington University...ing Harbor Laboratory and Iowa State University ha... , Click here for more information. ... , , , , , , , ...
(Date:11/20/2009)...tries have an opportunity to take the lead in two ...University of Valencia (UV), working together with...ve fabric of the Spanish biotechnology industry. T...tors have more clout than those in English-speakin...and plants has been overlooked by the leading coun...
(Date:11/20/2009)...PRNewswire/ -- Veridiam (www.veridiam.com) won the... category at the 2009 Workplace Excellence Awards.... for Human Resources Management and recognize inno...,, Veridiam was one of nine winners, selected f...nored at the recent awards ceremony. San Diego-bas...
(Date:11/20/2009)...RNewswire-FirstCall/ -- Dendreon Corporation (Nasd... Drug Administration (FDA) provided written acknow...ense Application (BLA) for PROVENGE® (sipuleu...ed a Prescription Drug User Fee Act (PDUFA) date o...ndreon,s amended BLA. Dendreon is seeking licensu...
Breaking Biology Technology:Amaizing: Corn genome decoded 2Amaizing: Corn genome decoded 3Amaizing: Corn genome decoded 4Spanish biotechnology should focus on food and plant sectors to be more competitive 2Veridiam Wins Workplace Excellence Crystal Award in Mid-Size Company Category 2Dendreon Receives FDA Acknowledgement of Complete Response 2Dendreon Receives FDA Acknowledgement of Complete Response 3
...s Midland,Company (NYSE: ADM ) announced that Wil...ected to retire by year end., In August 2007, Cam...any,s business strategy for Asian investments and ...the Company,s strategic planning group,under the d...rategic,Planning. John Rice, executive vice presid...
...al,(Nasdaq: PRAI ), a leading clinical research o...ers has been named its senior vice president of hu...approach to human resources that will,help PRA gro...is background,includes labor and employment law in...in business management and human resources. Jeff h...
...oration, an,orthopedic implants company focused on...oday that the U.S. Food and Drug Administration,ha...Valeo(TM) Pedicle Screw,system., The Valeo Pedicl...e,screw system incorporating features that are aim... positioning of these spinal implants. The Valeo,P...
Other Biology Technology:ADM Executive Vice President Bill Camp to Retire 2Chambers Joins PRA International as Senior Vice President of Human Resources 2Amedica Receives FDA 510(k) Clearance for Valeo(TM) Pedicle Screw System 2
(Date:11/22/2009)...s have succeeded in producing the polymers used fo... than through the use of fossil fuel based chemica...low for the production of environmentally consciou...nal Biotechnology and Bioengineering to mark the...ecules found in everyday life in the form of plast...
(Date:11/22/2009)...entoried an astonishing abundance, diversity and d...own sunlight - creatures that somehow manage a liv...~3 miles) below the ocean waves. , Revealed via...nologies, animals known to thrive in an eternal wa...ion of species ranging from crabs to shrimp to wor...
(Date:11/22/2009)...ease the likelihood of immune complications follow...team of researchers reports in the November 22 adv...ene, called UGT2B17, is missing from the donor,s g...have a significantly greater risk of a serious sid...ich immune cells from the donor attack tissues in ...
Breaking Biology News(10 mins):Bioengineers succeed in producing plastic without the use of fossil fuels 2Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 2Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 3Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 4Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 5Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 6Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 7Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 8Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 9Gene mismatch influences success of bone marrow transplants 2Gene mismatch influences success of bone marrow transplants 3Gene mismatch influences success of bone marrow transplants 4BioVex Agrees SPA With the FDA for a Pivotal Phase III Study With OncoVEX 28GM CSF 29 in Head and Neck Cancer 14049 1BioVex Agrees SPA With the FDA for a Pivotal Phase III Study With OncoVEX 28GM CSF 29 in Head and Neck Cancer 14049 2BioVex Agrees SPA With the FDA for a Pivotal Phase III Study With OncoVEX 28GM CSF 29 in Head and Neck Cancer 14049 3BioVex Agrees SPA With the FDA for a Pivotal Phase III Study With OncoVEX 28GM CSF 29 in Head and Neck Cancer 14049 4Palatin Technologies Inc Announces PL 3994 Poster Presentation at 2009 Heart Failure Society of America Annual Meeting 57162 1Palatin Technologies Inc Announces PL 3994 Poster Presentation at 2009 Heart Failure Society of America Annual Meeting 57162 2Palatin Technologies Inc Announces PL 3994 Poster Presentation at 2009 Heart Failure Society of America Annual Meeting 57162 3CBI Hosts Life Sciences Summit on International Trade Compliance 14047 1CBI Hosts Life Sciences Summit on International Trade Compliance 14047 2
...technology promises to speed up the accurate sorti...e detection and treatment of disease. , Separating...lood is becoming increasingly important for unders...e molecular sieve developed by MIT engineers is mo...otential to be much faster. , The team,s results ...
...a day or more to get lab results back from the doc...Using nanotechnology, a team of University of Geor...at can detect viruses as diverse as influenza, HIV...aving time, the technique ?which is detailed in th...d save lives by rapidly detecting a naturally occu...
...he most common bacteria in the Earth, Shewanella o...r respiration. But in the absence of oxygen, Shewa...rticles may also have adsorbed heavy metals on the...and bioavailability of iron and environmental cont... student Saumyaditya Bose and Professor Michael Ho...
Other Biology News:MIT's molecular sieve advances protein research 2Silver bullet: UGA researchers use laser, nanotechnology to rapidly detect viruses 2Silver bullet: UGA researchers use laser, nanotechnology to rapidly detect viruses 3Particle size matters to bacteria ability to immobilize heavy metals 2Particle size matters to bacteria ability to immobilize heavy metals 3
...tic particle based purification systems provide hi... any sample. They offer increased throughput and r...es three systems- KingFisher, KingFisher mL and Ki...0 l. Each system consists of an instrument, specia...
...ifically engineered for efficient drying down of s...glass cover and a post-trap with ammonia neutraliz...-free processing of samples in ammonium hydroxide....hetic Oligos , Comes standard with a glass li...
...ac™ Concentrators set the standard for sampl...SC210A SpeedVac with large chamber uses a combinat...ultiple samples in a single run. , SC210A comes eq... for long lasting chemical compatibility , ...
SPD1010 Integrated SpeedVac System from Thermo Scientific
Biology Products: